Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.

Saved in:
Bibliographic Details
Title: Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.
Authors: Walz JS; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany., Kowalewski DJ; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany., Backert L; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; c Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science , University of Tübingen , Tübingen , Germany., Nelde A; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany., Kohlbacher O; c Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science , University of Tübingen , Tübingen , Germany.; d Quantitative Biology Center , University of Tübingen , Tübingen , Germany.; e Biomolecular Interactions , Max Planck Institute for Developmental Biology , Tübingen , Germany., Weide B; f Department of Dermatology , University Hospital Tübingen , Tübingen , Germany., Kanz L; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany., Salih HR; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.; g Clinical Collaboration Unit Translational Immunology , German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen , Tübingen , Germany., Rammensee HG; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; h German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen , Tübingen , Germany., Stevanović S; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; h German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen , Tübingen , Germany.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2018 Aug; Vol. 59 (8), pp. 1949-1958. Date of Electronic Publication: 2018 Jan 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first